ADVFN Logo ADVFN

No pudimos encontrar ningún resultado para:
Asegúrate de que la ortografía sea correcta o intenta ampliar tu búsqueda.

Tendencias Ahora

Listas Principales

Parece que no has iniciado sesión.
Haz clic en el botón de abajo para iniciar sesión y ver tu historial reciente.

Regístrate

¿Ya eres miembro? Iniciar sesión

Los Principales Corredores en Línea

Más Corredores en Línea

Datos
Noticias
Herramientas
Mercados
Descubrir

Hot Features

Follow Feed

Conéctese con traders e inversores en nuestra comunidad Follow Feed.

Flujo de Opciones

Explora datos de opciones completos y utiliza filtros avanzados con Options Flow.

Monitor

Organiza y monitorea tu lista de seguimiento de acciones y activos con Monitor.
Iniciar Sesión Premium IconPremium Help Menu
S&P 500
5,116.17
0.32%
Dow Jones
38,386.09
0.38%
US Dollar vs MXN
17.01053
-0.02%
Brent Oil
87.39
0.12%
Bitcoin
61,874.43
-3.07%
Registration Strip Icon for alerts Regístrate para obtener alertas en tiempo real, cartera personalizada y movimientos del mercado.
Regístrate
  1. Inicio
  2. Invertir
  3. Acciones
  4. Estados Unidos
  5. NYSE
  6. Nevro Corp (NVRO)

  7. Nevro Corp (NVRO) Noticias

NVRO Nevro Corp

11.42
0.00 (0.00%)
Pre Mercado
Última actualización: 03:05:59
Retrasado por 15 minutos
Nombre de la Acción Símbolo de la Acción Bolsa de Valores Tipo de Valor
Nevro Corp NVRO NYSE Acción Común
  Variación del Día (ptos.) Variación del Día (%) Último Precio Hora
Upgrade Icon
0.00 0.00% 11.42 03:05:59
Precio de Apertura Precio Mínimo Precio Máximo Precio de cierre Precio Anterior
11.42
más cotizaciones de acciones »

Noticias Recientes

Fecha Hora Fuente Noticia
17/4/202407:30PRNUSNevro to Report First-Quarter 2024 Financial Results and..
11/3/202415:53EDGAR2Form 4 - Statement of changes in beneficial ownership of..
11/3/202415:52EDGAR2Form 4 - Statement of changes in beneficial ownership of..
11/3/202415:51EDGAR2Form 4 - Statement of changes in beneficial ownership of..
11/3/202415:50EDGAR2Form 4 - Statement of changes in beneficial ownership of..
11/3/202415:49EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06/3/202417:25EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05/3/202415:18EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05/3/202415:16EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05/3/202415:15EDGAR2Form 4 - Statement of changes in beneficial ownership of..
01/3/202416:56EDGAR2Form 4 - Statement of changes in beneficial ownership of..
01/3/202416:55EDGAR2Form 4 - Statement of changes in beneficial ownership of..
28/2/202415:10PRNUSNevro Receives FDA 510(k) Clearance to Use SI Fixation..
23/2/202416:08EDGAR2Form S-8 - Securities to be offered to employees in employee..
22/2/202415:19EDGAR2Form 4 - Statement of changes in beneficial ownership of..
22/2/202415:16EDGAR2Form 3 - Initial statement of beneficial ownership of..
21/2/202415:11EDGAR2Form 8-K - Current report
21/2/202415:09EDGAR2Form 8-K - Current report
21/2/202415:06PRNUSNevro Enters Into Cooperation Agreement With Engaged Capital
21/2/202415:05PRNUSNevro Reports Fourth-Quarter and Full-Year 2023 Financial..
14/2/202414:47EDGAR2Form SC 13G - Statement of acquisition of beneficial..
14/2/202414:38EDGAR2Form SC 13G - Statement of acquisition of beneficial..
01/2/202415:30PRNUSNevro Announces Consensus Statement Supporting..
29/1/202415:30PRNUSNevro to Report Fourth-Quarter and Full-Year 2023 Financial..
18/1/202415:15PRNUSNevro Announces Positive Coverage Update from Carelon..
17/1/202415:15PRNUSNevro to Highlight 25 Scientific Abstracts at 2024 North..
10/1/202423:15EDGAR2Form EFFECT - Notice of Effectiveness
10/1/202416:26EDGAR2Form 424B3 - Prospectus [Rule 424(b)(3)]
09/1/202407:41EDGAR2Form 8-K - Current report
09/1/202407:30PRNUSNevro Announces Preliminary Fourth-Quarter and Full-Year..
08/1/202416:25EDGAR2Form 4 - Statement of changes in beneficial ownership of..
04/1/202415:15PRNUSNevro to Present at 42nd Annual J.P. Morgan Healthcare..
03/1/202415:51EDGAR2Form 4 - Statement of changes in beneficial ownership of..
11/12/202308:00EDGAR2Form SC 13D - General statement of acquisition of beneficial..
05/12/202316:16EDGAR2Form 4 - Statement of changes in beneficial ownership of..
01/12/202305:07EDGAR2Form 8-K - Current report
30/11/202316:19PRNUSNevro Announces Acquisition of Vyrsa™ Technologies
30/11/202315:59EDGAR2Form 4 - Statement of changes in beneficial ownership of..
30/11/202315:56EDGAR2Form 4 - Statement of changes in beneficial ownership of..
20/11/202306:00PRNUSNevro Delivers Long-Term Relief with High-Frequency Spinal..
14/11/202317:54EDGAR2Form 4 - Statement of changes in beneficial ownership of..
01/11/202315:57EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
01/11/202315:07EDGAR2Form 8-K - Current report
01/11/202315:01PRNUSNevro Reports Third Quarter 2023 Financial Results, Provides..
06/10/202316:14EDGAR2Form 4 - Statement of changes in beneficial ownership of..
04/10/202306:00PRNUSNevro to Report Third Quarter 2023 Financial Results
03/10/202316:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
18/9/202306:00PRNUSNew Data Demonstrate the Health Economic Benefits of Nevro's..
06/9/202316:50EDGAR2Form 4 - Statement of changes in beneficial ownership of..
30/8/202315:49EDGAR2Form 4 - Statement of changes in beneficial ownership of..

Su Consulta Reciente

NYSE
NVRO
Nevro
Delayed Upgrade Clock
ADVFN Logo

México
Empresa
Negocios
Popular
Obtener la aplicación

Soporte: (55) 4170 8128 | soporte@advfn.mx

Al acceder a los servicios disponibles de ADVFN usted acepta quedar sujerto a los Términos y Condiciones

© 2024 ADVFN PLC - Todos los derechos reservados